#United States #INOVIO #DNA medicines #Plymouth Meeting #HPV Treatments

INOVIO Pharmaceuticals to Engage in Significant Investor Conferences

INOVIO Pharmaceuticals, Inc. (NASDAQ: INO), a pioneering biotechnology firm, is gearing up to participate in two major investor conferences. Focused on the development of innovative DNA medications, INOVIO primarily dedicates its efforts to combatting HPV-related conditions, various cancers, and infectious diseases. This opportunity aims to strengthen investor relationships and unveil advancements in their research and development strategies.

Conference Details

The first event is the Jefferies Global Healthcare Conference, scheduled for Wednesday, November 18, at 12:00 PM EST (5:00 PM GMT). INOVIO will deliver a presentation that will be webcasted for global accessibility. Interested parties can follow the live webcast here.

Following that, INOVIO will also take part in the Piper Sandler 38th Annual Healthcare Conference on Tuesday, December 1, from 2:00 to 2:25 PM EST. This session will be formatted as a fireside chat, providing an informal environment for discussions about the company’s technology and future goals. The webcast link can be found here, where attendees can access a replay for 90 days following the conference.

Management Engagement

During these conferences, senior officials from INOVIO's management team will conduct one-on-one meetings with key investors. These interactions will present an excellent opportunity for investors to gain insights into INOVIO's current projects, financial health, and the potential impact of their innovative medicines on public health.

About INOVIO Pharmaceuticals

Founded on the principles of scientific inquiry and discovery, INOVIO is committed to the advancement of DNA medicine technology. They focus on delivering robust therapeutic solutions that empower the body to create its own defenses against diseases, thus revolutionizing the treatment landscape for severe health threats. Through refined methods in DNA design and delivery, INOVIO is on a mission to tackle significant health challenges, especially those caused by HPV and other malignancies.

The company's official website provides further information on their ongoing projects and technological advancements. In addition to various clinical initiatives, INOVIO maintains an active presence on social media platforms such as LinkedIn and X (formerly Twitter).

Future Directions

As INOVIO collaborates with investors, stakeholders, and the greater scientific community, the company aspires to accelerate the practical application of its discoveries. Each conference represents a strategic platform where INOVIO can showcase their commitment to groundbreaking research and engage with forward-thinking investors who share their vision for pioneering health solutions.

This remarkable initiative by INOVIO exemplifies their proactive approach within the biotech sector. The presentations and discussions at these conferences could set the stage for future partnerships and advancements that might significantly influence healthcare outcomes globally.